|
|
Volumn 37, Issue 3, 2014, Pages 356-357
|
|
Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
CLOPIDOGREL;
PLASMINOGEN ACTIVATOR;
RETEPLASE;
TENEKTEPLASE;
TICAGRELOR;
UNCLASSIFIED DRUG;
ADENOSINE;
PURINERGIC P2Y RECEPTOR ANTAGONIST;
ANGIOCARDIOGRAPHY;
BLOOD CLOT LYSIS;
CLINICAL EFFECTIVENESS;
CORONARY ARTERY BYPASS GRAFT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPNEA;
FIBRINOLYTIC THERAPY;
HEART FAILURE;
HUMAN;
LETTER;
LOADING DRUG DOSE;
MULTICENTER STUDY (TOPIC);
NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
OUTCOME ASSESSMENT;
PERCUTANEOUS CORONARY INTERVENTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
UNSPECIFIED SIDE EFFECT;
ADULT;
AGED;
ANALOGS AND DERIVATIVES;
CLINICAL TRIAL;
FEMALE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
MYOCARDIAL INFARCTION;
PATHOPHYSIOLOGY;
ADENOSINE;
ADULT;
AGED;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PURINERGIC P2Y RECEPTOR ANTAGONISTS;
THROMBOLYTIC THERAPY;
|
|
EID: 84898538546
PISSN: 09295305
EISSN: 1573742X
Source Type: Journal
DOI: 10.1007/s11239-013-0972-2 Document Type: Letter |
|
Times cited : (6)
|
|
References (5)
|
